Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Renshen Yangrong
- Development stage
- Unknown
- Lead developer
- Beijing Tong Ren Tang
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jiawei Renshen Yangrong is a Traditional Chinese Medicine (TCM) formulation that serves as an augmented version of the classic Renshen Yangrong Tang (Ginseng Nutritive Decoction). It is primarily indicated for the treatment of "Qi and Blood Deficiency" syndromes, which manifest as extreme fatigue, palpitations, shortness of breath, insomnia, and poor appetite. The formula is a complex mixture of botanical extracts, typically including Panax ginseng, Astragalus membranaceus, and Angelica sinensis, which work synergistically to tonify the spleen and heart. It is frequently used in clinical practice for post-operative recovery, management of chronic illnesses, and treatment of anemia or neurasthenia. The "Jiawei" (augmented) prefix indicates the addition of specific herbs to the base formula to enhance its therapeutic profile for specific patient populations.
- Other names
- Jiawei Renshen Yangrong Wan加味人参养荣丸Modified Ginseng Nutritive FormulaAugmented Ginseng Nutritive Decoction
Beyond the preview
Go deeper on Jiawei Renshen Yangrong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiawei Renshen Yangrong.